Blonanserin

布南色林

Report date: 2026/03/17 16:09:31
NME

Base Information

Drug NameBlonanserin
Drug Alias Nameblonanserina布南瑟林布蓝色林blonanserinumLonasen +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryJapan
Original Approved Date2008/01/25
Country/TerritoryUkraineTaiwanPhilippines +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSumitomo Dainippon Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDainippon Sumitomo Pharma Co LtdSumitomo Dainippon Pharma Co Ltd
Inactive CompaniesJiangsu Hansoh Pharmaceutical Group Co LtdSumitomo Pharmaceuticals Co LtdNitto Denko Corporation, Tohoku Plant +[10] 
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN05
Related LinksWikipediaDrugBankKEGG